ArticleWorld journal of hepatology2014

Skin toxicity predicts efficacy to sorafenib in patients with advanced hepatocellular carcinoma.

Masako Shomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.